Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18355920.
- Also identified by DOI 10.1016/j.ophtha.2008.01.019.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To examine the decrease in the intraocular concentration of intravitreally injected triamcinolone acetonide over an 8-month period in a rabbit model. Experimental study. The study included 18 white New Zealand rabbits. The animals received an intravitreal injection of 6 mg triamcinolone acetonide. Vitreous and aqueous humor samples of the anterior and posterior chamber were taken at the first and third day, at 1 and 2 weeks, and at 1, 1.5, 2, 3, 6, and 8 months. The concentrations of triamcinolone were analyzed using a high-phase liquid chromatography assay. Intraocular concentration of triamcinolone during follow-up. Over the entire study period, triamcinolone concentrations were significantly higher in the vitreous samples than in the anterior chamber samples (day 1, 14 434+/-10 768 microg/l vs. 21.0+/-18.9 microg/l; day 30, 571.3+/-329.6 microg/l vs. 6.1+/-1.6 microg/l; month 8, 70.7+/-37.0 microg/l vs. 3.3+/-1.6 microg/l). In the anterior chamber, the triamcinolone concentrations were highest at 3 days after the injection (28.9+/-24.5 microg/l), and in the vitreous, the concentrations were highest at the first day (14,434.0+/-10,768 microg/l). Triamcinolone levels in the vitreous and in the anterior chamber followed a 2-compartment model, with an exponential decrease in the concentration within the first 4 weeks, followed by a steady decline over the following months. At 8 months, the triamcinolone concentrations were 70.7+/-37.0 microg/l in the vitreous samples and 3.3+/-1.6 microg/l in the anterior chamber samples. The decrease in the concentration of triamcinolone after an intravitreal injection of 6 mg in rabbits follows a 2-compartment model, with an exponential decrease in the first 4 weeks followed by a more linear decrease. During the entire study period, the triamcinolone concentration was significantly higher in the vitreous than in the anterior chamber. After a single intravitreal triamcinolone injection of 6 mg in rabbits, triamcinolone is detectable for at least 8 months after the injection.
Medical subject headings
- Glucocorticoids
- Triamcinolone Acetonide
- Vitreous Body